Jan Tode, MD, FEBO

Tode is a senior ophthalmologist and translational vision science researcher. He is deputy head of the Department at the Hannover Medical School in Germany and CEO of enVision Science UG. Tode’s research focus lies at the intersection of retinal disease (especially AMD), uveitis, and novel therapeutic approaches (including selective retina laser therapy and photothermal stimulation). He has published more than 50 peer-reviewed articles and is a guest editor for laser therapy special issues in ophthalmology.

E: tode.jan@mh-hannover.de

Financial disclosure: Consultant for AbbVie, Bayer, enVision Science, Novartis, OD-OS, Roche, Santen.